.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Deloitte
Cantor Fitzgerald
Merck
McKesson
Novartis
Harvard Business School
Colorcon
Healthtrust
Daiichi Sankyo

Generated: December 12, 2017

DrugPatentWatch Database Preview

Betamethasone valerate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for betamethasone valerate and what is the scope of betamethasone valerate patent protection?

Betamethasone valerate
is the generic ingredient in eight branded drugs marketed by Perrigo Uk Finco, Riconpharma Llc, Taro Pharm, Mylan Pharms Inc, G And W Labs Inc, Roaco, Fougera Pharms Inc, Perrigo New York, Pharmaderm, Pharmafair, Taro, Savage Labs, Schering, Actavis Mid Atlantic, Sti Pharma Llc, and Teva Pharms, and is included in thirty-one NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Betamethasone valerate has twenty-seven patent family members in twenty countries.

There are sixty-six drug master file entries for betamethasone valerate. Twenty suppliers are listed for this compound. There is one tentative approval for this compound.

Pharmacology for betamethasone valerate

Medical Subject Heading (MeSH) Categories for betamethasone valerate

Tentative approvals for BETAMETHASONE VALERATE

Applicant Application No. Strength Dosage Form
u► Subscribe0.12%FOAM;TOPICAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
RoacoBETADERMbetamethasone valerateCREAM;TOPICAL018839-001Jun 30, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Savage LabsBETATREXbetamethasone valerateLOTION;TOPICAL018867-001Aug 31, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Riconpharma LlcBETAMETHASONE VALERATEbetamethasone valerateAEROSOL, FOAM;TOPICAL207144-001May 24, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Perrigo New YorkBETAMETHASONE VALERATEbetamethasone valerateOINTMENT;TOPICAL071478-001Dec 23, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
PharmadermBETAMETHASONE VALERATEbetamethasone valerateCREAM;TOPICAL018860-002Aug 31, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fougera Pharms IncBETAMETHASONE VALERATEbetamethasone valerateOINTMENT;TOPICAL018865-001Aug 31, 1983ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Taro PharmBETAMETHASONE VALERATEbetamethasone valerateAEROSOL, FOAM;TOPICAL208204-001May 24, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
PharmadermBETAMETHASONE VALERATEbetamethasone valerateOINTMENT;TOPICAL018864-001Aug 31, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
ScheringVALISONEbetamethasone valerateOINTMENT;TOPICAL016740-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TaroDERMABETbetamethasone valerateCREAM;TOPICAL072041-001Jan 6, 1988ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: betamethasone valerate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Pharms IncLUXIQbetamethasone valerateAEROSOL, FOAM;TOPICAL020934-001Feb 28, 1999► Subscribe► Subscribe
Mylan Pharms IncLUXIQbetamethasone valerateAEROSOL, FOAM;TOPICAL020934-001Feb 28, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: betamethasone valerate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,126,920 Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: betamethasone valerate

Country Document Number Estimated Expiration
Germany69630593► Subscribe
South Korea100427492► Subscribe
Spain2210349► Subscribe
Portugal813413► Subscribe
Czech Republic9702758► Subscribe
Poland183730► Subscribe
European Patent Office0813413► Subscribe
Slovakia119097► Subscribe
China1082817► Subscribe
Japan4557310► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Novartis
Express Scripts
Healthtrust
Moodys
Accenture
US Army
US Department of Justice
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot